BLG 699 Lecture Notes - Lecture 11: Johnson & Johnson, Biosimilar, Prescription Drug
Document Summary
Blg 699 wk 11 cost of developing drugs. New medicines are slow to finish the cross line. Fda an increasingly unreasonable hunger for statistical certainty of the part of the fda . Larger studies - protect patients from unsafe medicines. Tufts center for the study of drug development. Briefing - cost of developing a new drug. The estimated average pre-tax industry cost per new prescription drug approval is: . 6 million. Elements used to determine fully allocated new compound r & d costs. Out of pocket clinical costs (all indications, long-term animal testing, overhead, Cmc during clinical testing and prior to first approval) Out-of-pocket discovery research and preclinical development costs. Clinical approval success and phase attrition rates. How drug companies keep insulin prices high - cbs news. Background information in the study said about 6 million people currently take insulin in us. Synthetic insulins are some of the highest-grossing medicines on the market.
